Swedish rare diseases company Sobi has appointed Lars Dreiøe as senior vice president chief quality and compliance officer.
He will join the firm in January from Danish allergy vaccine company ALK Abelló, where he was international head of quality.
Geoffrey McDonough, president and CEO at Sobi, said: “Sobi has been expanding the scope and geographic area of operations and the demands and complexity of external regulations governing our business has also increased.
“Lars will sustain and deepen our global commitment to quality in all aspects of our work, and will be a valuable addition to our senior leadership team.”
Dreiøe has 20 years of experience in the biotech and pharmaceutical industries in quality, manufacturing, product safety and regulatory affairs.
He started his industry career with Lundbeck as a production chemist and subsequently held senior roles with Novo Nordisk.